SOUTH PLAINFIELD, N.J., April 21 /PRNewswire/ -- PTC Therapeutics, Inc.
(PTC), a biopharmaceutical company focused on the discovery, development,
and commercialization of orally administered, proprietary small-molecule
drugs that target post-transcriptional control processes, today announced
the promotion of Claudia Hirawat to Senior Vice President of Corporate
Development.
(Logo: http://www.newscom.com/cgi-bin/prnh/20010919/PTCLOGO )
"I am extremely pleased to announce this promotion. Claudia has made
significant contributions to our company, providing leadership across
multiple areas including leading our efforts in establishing our business
collaborations," commented Stuart Peltz, Ph.D., President and CEO of PTC
Therapeutics, Inc.
Ms. Hirawat was most recently Vice President of Corporate Development
at PTC. Her responsibilities focused on business development, public
relations and advocacy group relations. In her new role as Senior Vice
President of Corporate Development, Ms. Hirawat will focus on business
development, advocacy group relations and commercial development.
Ms. Hirawat joined PTC in 2000 as the company's seventh employee. Prior
to PTC, Ms. Hirawat was a Vice President at LedbetterStevens, a management
consulting and senior-level retained search firm in New York focused
exclusively in the biopharmaceutical area.
About PTC Therapeutics, Inc.
PTC is a biopharmaceutical company focused on the discovery,
development, and commercialization of orally administered, proprietary
small-molecule drugs that target post-transcriptional control processes.
Post-transcriptional control processes regulate the rate and timing of
protein production and are of central importance to proper cellular
function. PTC has assembled proprietary technologies and extensive
knowledge of post-transcriptional control processes that it applies in its
drug discovery and development activities. PTC's current pipeline of
clinical and preclinical product candidates addresses multiple indications,
including genetic disorders, oncology, and infectious diseases.
SOURCE PTC Therapeutics, Inc.
 back to top
Related links:
http://www.ptcbio.com
Photo Notes:http://www.newscom.com/cgi-bin/prnh/20010919/PTCLOGO
CONTACT:
Jane Baj of PTC Therapeutics, Inc.,
+1-908-222-7000, x167, jbaj@ptcbio.com
|
